1. Fass RJ. Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Antimicrobial Agents and Chemotherapy1987;31:148–50.
2.
2. Powers T, Bingham DH. Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy. Am J Hosp Pharm1990;47:1781–4.
3.
3. Cooke J, Cairns CJ, Tillotson GS, et al. Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials. Ann Pharmacother1993;27: 785–9.
4.
4. Forrest A, Nix DE, Ballow CH, et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents Chemotherapy1993;37:1073–81.
5.
5. Hoflken G, Borner K, Glatzel PD, et al. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol1985;3:345.
6.
6. Deppermann KM, Lode H.Fluoroquinolones. Interaction profile during enteral absorption. Drugs1993;45(Suppl 3):65–72.
7.
7. Noer BL, Angaran DM. The effect of enteral feedings on ciprofloxacin pharmacokinetics. Pharmacother1990;10:254 [Abstract].
8.
8. Piccolo ML, Toossi Z, Goldman M.Effect of coadministration of a nutritional supplement on ciprofloxacin absorption. Am J Hosp Pharm1994;51:2697–9.
9.
9. Healy DP, Brodbeck MC, Clendening CE. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrobial Agents Chemotherapy1996;40:6–10.
10.
10. Mueller BA, Brierton DG, Abel SR, et al. Effect of enteral feeding with Ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrobial Agents Chemotherapy1994;38:2101–5.
11.
11. Yuk JH, Nightingale CH, Sweeney KR, et al. Relative bio-availability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding. Antimicrobial Agents Chemotherapy1989;33:1118–20.
12.
12. Marie SD, VandenBergh MFQ, Buijk SLCE, et al. Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections. Intensive Care Med1998;24:343–6.
13.
13. Cohn SM, Sawyer MD, Burns GA, et al. Enteric absorption of ciprofloxacin during tube feeding in the critically ill. J Antimicrobial Chemotherapy1996;38:871–6.
14.
14. Yuk JH, Nightingale CH, Quintiliani R, et al. Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition. Diagn Microbiol Infec Dis1990;33:99–102.
15.
15. Staib AH, Beermann D, Harder S, et al. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). Am J Med1989;87(Suppl 5A):66S-69S.
16.
16. Cohn SM, Cohn KA, Rafferty MJ, et al. Enteric absorption of ciprofloxacin during the immediate postoperative period. J Antimicrobial Chemotherapy1995;36:717–21.
